Glenmark Pharms Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GLENMARK PHARMS LTD, and what generic and branded alternatives to GLENMARK PHARMS LTD drugs are available?
GLENMARK PHARMS LTD has eighty-four approved drugs.
There are eight tentative approvals on GLENMARK PHARMS LTD drugs.
Drugs and US Patents for Glenmark Pharms Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glenmark Pharms Ltd | ICATIBANT ACETATE | icatibant acetate | INJECTABLE;SUBCUTANEOUS | 213222-001 | May 21, 2021 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Glenmark Pharms Ltd | EZETIMIBE | ezetimibe | TABLET;ORAL | 078560-001 | Jun 26, 2015 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glenmark Pharms Ltd | TELMISARTAN | telmisartan | TABLET;ORAL | 090032-001 | Jul 7, 2014 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glenmark Pharms Ltd | LIDOCAINE | lidocaine | OINTMENT;TOPICAL | 206498-001 | Sep 9, 2016 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glenmark Pharms Ltd | RUFINAMIDE | rufinamide | TABLET;ORAL | 205075-002 | May 16, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glenmark Pharms Ltd | LACOSAMIDE | lacosamide | TABLET;ORAL | 205006-002 | Mar 17, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glenmark Pharms Ltd | OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 203281-003 | May 25, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.